These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23587442)

  • 1. Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.
    Spector Y; Fridman E; Rosenwald S; Zilber S; Huang Y; Barshack I; Zion O; Mitchell H; Sanden M; Meiri E
    Mol Oncol; 2013 Jun; 7(3):732-8. PubMed ID: 23587442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas.
    Wang Q; Gan H; Chen C; Sun Y; Chen J; Xu M; Weng W; Cao L; Xu Q; Wang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):176. PubMed ID: 29208006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Renal Cell Carcinoma.
    Sellitti DF; Doi SQ
    Microrna; 2015; 4(1):26-35. PubMed ID: 26165467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.
    Beaumont M; Dugay F; Kammerer-Jacquet SF; Jaillard S; Cabillic F; Mathieu R; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA;
    Hum Pathol; 2019 Oct; 92():81-90. PubMed ID: 31437522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of molecular diagnosis of renal cell carcinoma].
    Junker K
    Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.
    Trilla-Fuertes L; Miranda N; Castellano D; López-Vacas R; Farfán Tello CA; de Velasco G; Villacampa F; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; Espinosa E; Fresno Vara JÁ; Pinto Á; Gámez-Pozo A
    PLoS One; 2020; 15(2):e0229075. PubMed ID: 32109249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
    Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM
    Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.